Suchergebnisse - "Okada, Annabelle A"

PubPharm (16)

1

Subfoveal choroidal thickness after brolucizumab therapy for neovascular age-related macular degeneration : a short-term multicenter study

enthalten in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2022

von Tamashiro, T. | Tanaka, K. | Itagaki, K. | +18

2

Relationship between retinal fluid and visual acuity in patients with exudative age-related macular degeneration treated with intravitreal aflibercept using a treat-and-extend regimen : subgroup and post-hoc analyses from the ALTAIR study

enthalten in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2021

von Ohji, M. | Okada, A. | Sasaki, K. | +4

ErratumIn: Graefes Arch Clin Exp Ophthalmol. 2022 Jul;260(7):2395-2396. - PMID 35366082

3

MANAGEMENT OF RETINAL PIGMENT EPITHELIUM TEAR DURING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY

enthalten in: Retina (Philadelphia, Pa.) | 2021

von Mitchell, P. | Rodríguez, F. | Joussen, A. | +5

4

Anti-VEGF intravitreal injections in the era of COVID-19 : responding to different levels of epidemic pressure

enthalten in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2021

von Korobelnik, J. | Loewenstein, A. | Eldem, B. | +12

5

Macular atrophy after aflibercept therapy for neovascular age-related macular degeneration : outcomes of Japanese multicenter study

enthalten in: Japanese journal of ophthalmology | 2020

von Koizumi, H. | Yamamoto, A. | Ogasawara, M. | +6

6

Guidance for anti-VEGF intravitreal injections during the COVID-19 pandemic

enthalten in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie | 2020

von Korobelnik, J. | Loewenstein, A. | Eldem, B. | +12

CommentIn: Graefes Arch Clin Exp Ophthalmol. 2020 Jun;258(6):1335-1337. - PMID 32322965

7

SUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY

enthalten in: Retina (Philadelphia, Pa.) | 2020

von Wong, D. | Lambrou, G. | Loewenstein, A. | +3

8

The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab

enthalten in: American journal of ophthalmology | 2019

von Storey, P. | Tauqeer, Z. | Yonekawa, Y. | +26

9

One-Year Outcomes of a Treat-and-Extend Regimen of Aflibercept for Exudative Age-Related Macular Degeneration

enthalten in: Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde | 2017

von Yamamoto, A. | Okada, A. | Nakayama, M. | +2

10

Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration : Twelve-Month Results

enthalten in: Ophthalmology | 2016

von Koizumi, H. | Kano, M. | Yamamoto, A. | +5